Beijing Science Sun Pharmaceutical Co., Ltd. (SHE:300485)

Revenue by Segment

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2023	FY 2022	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015
Medicine Manufacturing	414.95M	475.92M	733.73M	1.05B	1.09B
Medicine Manufacturing Growth	-12.81%	-35.14%	-30.10%	-4.05%	-8.14%
Unallocated Other Operations	1.53M	646.39K	816.20K	1.15M	275.23K
Unallocated Other Operations Growth	136.73%	-20.81%	-28.80%	316.52%	-
Total	416.48M	476.57M	734.55M	1.05B	1.09B
Total Growth	-12.61%	-35.12%	-30.10%	-3.97%	-8.12%

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2023	FY 2022	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015
East China	123.50M	134.62M	185.84M	219.88M	233.93M
East China Growth	-8.26%	-27.56%	-15.48%	-6.01%	-
Northeast China	72.04M	83.39M	189.73M	235.78M	237.68M
Northeast China Growth	-13.61%	-56.05%	-19.53%	-0.80%	-
Central China	68.02M	94.57M	156.11M	241.46M	210.03M
Central China Growth	-28.07%	-39.42%	-35.35%	14.96%	-
Northern China	61.69M	72.48M	87.81M	167.86M	148.70M
Northern China Growth	-14.88%	-17.46%	-47.69%	12.88%	-
Southwest China	50.06M	48.50M	53.64M	80.30M	119.18M
Southwest China Growth	3.22%	-9.58%	-33.20%	-32.62%	-
South China	27.75M	27.91M	43.95M	75.67M	116.02M
South China Growth	-0.58%	-36.49%	-41.93%	-34.78%	-
Northwestern China	13.42M	15.10M	17.47M	29.86M	28.68M
Northwestern China Growth	-11.16%	-13.56%	-41.48%	4.12%	-
Total	416.48M	476.57M	734.55M	1.05B	1.09B
Total Growth	-12.61%	-35.12%	-30.10%	-3.97%	-8.12%

Source: S&P Global Market Intelligence.